News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
64,986 Results
Type
Article (3860)
Company Profile (5)
Press Release (61121)
Section
Business (28911)
Career Advice (142)
Deals (4379)
Drug Delivery (3)
Drug Development (7560)
Employer Resources (5)
FDA (1295)
Job Trends (2010)
News (40441)
Policy (2387)
Tag
Academia (112)
Accelerated approval (2)
Adcomms (1)
Allergies (4)
Alliances (2748)
ALS (4)
Alzheimer's disease (129)
Antibody-drug conjugate (ADC) (9)
Approvals (1348)
Artificial intelligence (13)
Autoimmune disease (2)
Automation (1)
Bankruptcy (27)
Best Places to Work (1469)
BIOSECURE Act (4)
Biosimilars (15)
Biotechnology (5)
Bladder cancer (25)
Brain cancer (3)
Breast cancer (64)
Cancer (369)
Cardiovascular disease (33)
Career advice (138)
CAR-T (14)
CDC (1)
Cell therapy (33)
Cervical cancer (7)
Clinical research (6817)
Collaboration (68)
Compensation (45)
Complete response letters (5)
COVID-19 (179)
CRISPR (7)
C-suite (17)
Cystic fibrosis (9)
Data (497)
Depression (6)
Diabetes (30)
Diagnostics (642)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (7)
Drug pricing (5)
Duchenne muscular dystrophy (12)
Earnings (25087)
Editorial (2)
Employer branding (3)
Employer resources (4)
Events (8071)
Executive appointments (30)
FDA (1684)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (46)
Gene editing (10)
Generative AI (1)
Gene therapy (26)
GLP-1 (88)
Government (236)
Guidances (217)
Healthcare (2064)
HIV (1)
IgA nephropathy (11)
Immunology and inflammation (10)
Indications (4)
Infectious disease (190)
Inflammatory bowel disease (13)
Influenza (5)
Intellectual property (11)
Interviews (12)
IPO (3002)
Job creations (615)
Job search strategy (136)
Kidney cancer (4)
Labor market (8)
Layoffs (63)
Legal (514)
Liver cancer (3)
Longevity (1)
Lung cancer (54)
Lymphoma (44)
Machine learning (1)
Manufacturing (30)
MASH (16)
Medical device (1478)
Medtech (1480)
Mergers & acquisitions (1426)
Metabolic disorders (79)
Multiple sclerosis (14)
NASH (3)
Neurodegenerative disease (5)
Neuropsychiatric disorders (2)
Neuroscience (191)
NextGen: Class of 2025 (705)
Non-profit (253)
Now hiring (1)
Obesity (31)
Opinion (16)
Ovarian cancer (15)
Pain (10)
Pancreatic cancer (12)
Parkinson's disease (15)
Partnered (2)
Patents (26)
Patient recruitment (18)
Peanut (1)
People (2213)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase I (1666)
Phase II (2686)
Phase III (3085)
Pipeline (882)
Policy (8)
Postmarket research (257)
Preclinical (507)
Press Release (2)
Prostate cancer (10)
Psychedelics (1)
Radiopharmaceuticals (26)
Rare diseases (49)
Real estate (411)
Recruiting (3)
Regulatory (1887)
Reports (9)
Research institute (132)
Resumes & cover letters (9)
Rett syndrome (3)
RSV (3)
Schizophrenia (16)
Series A (7)
Series B (2)
Sickle cell disease (6)
Special edition (1)
Spinal muscular atrophy (22)
Startups (248)
Stomach cancer (2)
Supply chain (2)
Tariffs (2)
Vaccines (79)
Venture capital (1)
Weight loss (17)
Women's health (3)
Date
Today (8)
Last 7 days (39)
Last 30 days (263)
Last 365 days (4251)
2025 (3019)
2024 (4678)
2023 (5229)
2022 (6549)
2021 (6328)
2020 (5318)
2019 (4328)
2018 (3448)
2017 (4329)
2016 (3097)
2015 (2824)
2014 (1931)
2013 (1190)
2012 (1535)
2011 (1647)
2010 (1508)
Location
Africa (140)
Alabama (7)
Alaska (1)
Arizona (16)
Asia (5065)
Australia (531)
California (1043)
Canada (290)
China (67)
Colorado (75)
Connecticut (60)
Delaware (51)
Europe (9658)
Florida (182)
Georgia (40)
Idaho (4)
Illinois (97)
India (3)
Indiana (65)
Iowa (1)
Japan (89)
Kansas (14)
Kentucky (4)
Louisiana (7)
Maine (16)
Maryland (116)
Massachusetts (821)
Michigan (29)
Minnesota (65)
Mississippi (1)
Missouri (8)
Montana (2)
Nebraska (2)
Nevada (16)
New Hampshire (8)
New Jersey (456)
New Mexico (1)
New York (340)
North Carolina (155)
Northern California (517)
Ohio (20)
Pennsylvania (226)
Puerto Rico (3)
South America (172)
South Carolina (1)
Southern California (419)
Tennessee (12)
Texas (125)
United States (4070)
Utah (41)
Virginia (8)
Washington D.C. (3)
Washington State (65)
West Virginia (1)
Wisconsin (7)
64,986 Results for "81".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Novo’s Headcount Rose 81% in Five Years as Revenue Climbed
As Novo Nordisk cuts 9,000 people from its organization in a restructuring effort,
BioSpace
looks back on the Danish pharma company’s rise.
September 10, 2025
·
1 min read
·
Annalee Armstrong
Job Trends
Greener Pastures? 81% of Employed Biopharma Professionals Want New Jobs,
BioSpace
Finds
Employed biopharma professionals are highly likely to look for new jobs in the next 12 months, although not quite as likely as their unemployed counterparts, according to a
BioSpace
LinkedIn poll. Three recruitment experts discuss the findings and what’s driving job searches.
July 31, 2025
·
4 min read
·
Angela Gabriel
Press Releases
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
August 18, 2025
·
3 min read
Press Releases
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
September 9, 2025
·
19 min read
Press Releases
Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
August 22, 2025
·
4 min read
Press Releases
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
August 28, 2025
·
7 min read
Press Releases
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
July 25, 2025
·
19 min read
Press Releases
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
July 31, 2025
·
3 min read
Press Releases
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
May 26, 2025
·
4 min read
Press Releases
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1
July 25, 2025
·
3 min read
1 of 6,499
Next
